arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

Programma

vrijdag 18 jan

08:30

Registration

09:00

Welcome

09:05

ESMO Guidelines 2019

David Planchard, Institut Gustave Roussy, France

09:30

Progression after TKI’s: What’s next

Joop de Langen, AvL

Targeted treatment for oncogene addicted NSCLC

The time of ‘one size fits all’ lies behind us. Platinum-doublet chemotherapy as first line therapy for all patients with advanced non-small-cell lung cancer (NSCLC), followed by second line docetaxel upon progression for fit patients is a treatment of the past.

Major progress has been made in diagnostics (from none up to next generation sequencing and whole exome or genome sequencing) and therapeutic management, resulting in personalized therapy for every lung cancer patient.

As the diagnostic and therapeutic management of NSCLC evolves, the treating physician (you) has to evolve in the same pace. A modern pulmonary oncologist needs to be a molecular biologist, chemotherapist, immunologist, tyrosine kinase inhibitorist and palliative specialist, combined in one person.

During this presentation, we will discuss the diagnostic work-up of patients with advanced stage NSCLC, the interpretation of genetic results (is this mutation targetable or not), the therapeutic options for oncogene driven NSCLC, the use of liquid and tissue biopsies to identify TKI resistance and strategies to overcome TKI resistance.

09:50

Thymoma and SCLC treatment 2019

Giuseppe Giaccone, Lombardi Comprehensive Cancer Center, USA

10:15

Break

11:00

Basics of IO treatment

Giorgio Scagliotti, Università di Torino, IT

11:25

The role of surgery in IO treatment

Joshua Sonett, NewYork-Presbyterian Hospital/Columbia University Medical Center, USA

11:50

The role of SBRT in IO treatment

Willemijn Theelen, AvL

12:10

The role of IO after concurrent chemo RT

Corey Langer, Abramson Cancer Center, USA

12:40

Lunch

14:00

Machiel van der Woude Stipendium

14:10

Vera Bonta Award

14:20

Tafel discussie : Longkankerscreening in Nederland

Moderator: Frenk van der Linden Panelleden: Robin Cornelissen (Erasmus MC) Lidia Barberio (Longkanker Nederland) Joost Zaat (Wetenschaps journalist, NTVG) Lukas Stalpers (radiotherapeut, AUMC) Wanda de Kanter (Stichting Rookpreventie Jeugd), Harry de Koning (ErasmusMC)

16:30

Closing remarks and reception